vs
Side-by-side financial comparison of BXP, Inc. (BXP) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
BXP, Inc. is the larger business by last-quarter revenue ($872.1M vs $493.8M, roughly 1.8× Pediatrix Medical Group, Inc.). BXP, Inc. runs the higher net margin — 15.3% vs 6.8%, a 8.4% gap on every dollar of revenue. On growth, BXP, Inc. posted the faster year-over-year revenue change (0.8% vs -1.7%). Over the past eight quarters, BXP, Inc.'s revenue compounded faster (1.3% CAGR vs -0.1%).
BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BXP vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $872.1M | $493.8M |
| Net Profit | $133.0M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | — | 9.9% |
| Net Margin | 15.3% | 6.8% |
| Revenue YoY | 0.8% | -1.7% |
| Net Profit YoY | 53.0% | 10.5% |
| EPS (diluted) | $1.69 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $872.1M | — | ||
| Q4 25 | $877.1M | $493.8M | ||
| Q3 25 | $871.5M | $492.9M | ||
| Q2 25 | $868.5M | $468.8M | ||
| Q1 25 | $865.2M | $458.4M | ||
| Q4 24 | $858.6M | $502.4M | ||
| Q3 24 | $859.2M | $511.2M | ||
| Q2 24 | $850.5M | $504.3M |
| Q1 26 | $133.0M | — | ||
| Q4 25 | $248.4M | $33.7M | ||
| Q3 25 | $-121.7M | $71.7M | ||
| Q2 25 | $89.0M | $39.3M | ||
| Q1 25 | $61.2M | $20.7M | ||
| Q4 24 | $-228.9M | $30.5M | ||
| Q3 24 | $83.6M | $19.4M | ||
| Q2 24 | $79.6M | $-153.0M |
| Q1 26 | — | — | ||
| Q4 25 | 58.8% | — | ||
| Q3 25 | 59.3% | — | ||
| Q2 25 | 59.2% | — | ||
| Q1 25 | 59.2% | — | ||
| Q4 24 | 59.7% | — | ||
| Q3 24 | 59.5% | — | ||
| Q2 24 | 59.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | -31.3% |
| Q1 26 | 15.3% | — | ||
| Q4 25 | 28.3% | 6.8% | ||
| Q3 25 | -14.0% | 14.5% | ||
| Q2 25 | 10.2% | 8.4% | ||
| Q1 25 | 7.1% | 4.5% | ||
| Q4 24 | -26.7% | 6.1% | ||
| Q3 24 | 9.7% | 3.8% | ||
| Q2 24 | 9.4% | -30.3% |
| Q1 26 | $1.69 | — | ||
| Q4 25 | $1.56 | $0.40 | ||
| Q3 25 | $-0.77 | $0.84 | ||
| Q2 25 | $0.56 | $0.46 | ||
| Q1 25 | $0.39 | $0.24 | ||
| Q4 24 | $-1.46 | $0.37 | ||
| Q3 24 | $0.53 | $0.23 | ||
| Q2 24 | $0.51 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $512.8M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $7.7B | $865.9M |
| Total Assets | $25.1B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $512.8M | — | ||
| Q4 25 | $1.5B | $375.2M | ||
| Q3 25 | $861.1M | $340.1M | ||
| Q2 25 | $447.0M | $224.7M | ||
| Q1 25 | $398.1M | $99.0M | ||
| Q4 24 | $1.3B | $229.9M | ||
| Q3 24 | $1.4B | $103.8M | ||
| Q2 24 | $685.4M | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $7.7B | — | ||
| Q4 25 | $5.1B | $865.9M | ||
| Q3 25 | $5.0B | $890.7M | ||
| Q2 25 | $5.3B | $833.8M | ||
| Q1 25 | $5.3B | $789.2M | ||
| Q4 24 | $5.4B | $764.9M | ||
| Q3 24 | $5.8B | $732.5M | ||
| Q2 24 | $5.8B | $706.5M |
| Q1 26 | $25.1B | — | ||
| Q4 25 | $26.2B | $2.2B | ||
| Q3 25 | $26.0B | $2.2B | ||
| Q2 25 | $25.6B | $2.1B | ||
| Q1 25 | $25.4B | $2.0B | ||
| Q4 24 | $26.1B | $2.2B | ||
| Q3 24 | $26.4B | $2.1B | ||
| Q2 24 | $25.5B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 1.5% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $407.8M | $114.1M | ||
| Q3 25 | $274.2M | $137.3M | ||
| Q2 25 | $353.1M | $137.2M | ||
| Q1 25 | $210.0M | $-117.5M | ||
| Q4 24 | $383.7M | $133.0M | ||
| Q3 24 | $286.1M | $91.8M | ||
| Q2 24 | $367.1M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | $362.7M | — | ||
| Q3 25 | $231.6M | — | ||
| Q2 25 | $281.5M | — | ||
| Q1 25 | $152.6M | — | ||
| Q4 24 | $312.5M | — | ||
| Q3 24 | $234.5M | — | ||
| Q2 24 | $332.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 41.4% | — | ||
| Q3 25 | 26.6% | — | ||
| Q2 25 | 32.4% | — | ||
| Q1 25 | 17.6% | — | ||
| Q4 24 | 36.4% | — | ||
| Q3 24 | 27.3% | — | ||
| Q2 24 | 39.1% | — |
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.1% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 8.2% | — | ||
| Q1 25 | 6.6% | — | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 4.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.64× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 3.97× | 3.49× | ||
| Q1 25 | 3.43× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 3.42× | 4.72× | ||
| Q2 24 | 4.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
